The Maudsley deprescribing guidelines : antidepressants, benzodiazepines, gabapentinoids and z-drugs /
"Deprescribing is increasingly recognized to be a key component of good prescribing - reducing doses when they are too high, and stopping medications when they are no longer needed. This process cannot occur in a vacuum of theoretical concerns but should take into account the patient's hea...
| Main Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Hoboken, N.J. :
Wiley Blackwell,
[2024]
|
| Series: | Maudsley guidelines series.
|
| Subjects: |
| Summary: | "Deprescribing is increasingly recognized to be a key component of good prescribing - reducing doses when they are too high, and stopping medications when they are no longer needed. This process cannot occur in a vacuum of theoretical concerns but should take into account the patient's health, current level of functioning and, importantly, their values and preferences. Deprescribing requires the same skill and experience as for the process of prescribing from prescribers, as well as support from pharmacists and other healthcare staff to get the best results."-- |
|---|---|
| Physical Description: | xvi, 568 pages : illustrations ; 25 cm. |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: | 9781119822981 111982298X |